Pharmacokinetic opportunities for combination therapy in migraine.
Fox
Anthony W
AW
EBD Group, Carlsbad, California 92009, USA.
Kori
Shashidhar H
SH
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism*; D055502:Secondary Prevention; D017366:Serotonin Receptor Agonists / Q000493:pharmacokinetics / Q000627:therapeutic use; D018170:Sumatriptan / Q000493:pharmacokinetics / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017366:Serotonin Receptor Agonists; D018170:Sumatriptan